About Neurolink
Neurolink is a company based in San Antonio (United States) founded in 2007. It operates as a B2B. Neurolink has raised $3.88 million across 2 funding rounds. Neurolink operates in a competitive market with competitors including NeuroPace, Cadence Neuroscience, Engage Therapeutics, NightWatch and Cyberonics, among others.
- Headquarter San Antonio, United States
- SectorsHealthcare
- Website neurolinkmedical.com
- Total Equity Funding$3.88M (USD)
in 2 rounds
- Latest Funding Round$2.26M (USD), Series A
Jan 2011
Funding Insights of Neurolink
Neurolink has successfully raised a total of $3.88M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.26 million completed in January 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.88M
- Total Rounds 2
- Last Round Series A — $2.26M
- First Round $1.62M
(Oct 2010)
All 2 funding rounds of Neurolink with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2011 | $2.26M | Series A | – | – | – |
| Oct 2010 | $1.62M | Seed | – | – | – |
Timeline of Neurolink
3 dated milestones of Neurolink across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Neurolink is founded.
- Funding First funding round of $1.6M.
- Funding Latest funding round, Series A, of $2.3M.
Competitors of Neurolink
Neurolink operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuroPace, Cadence Neuroscience, Engage Therapeutics, NightWatch and Cyberonics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| neuropace.com | 1997 | United States | $263.56M | 184 | Implantable neurostimulation systems for epilepsy treatment are developed. | |
| cadenceneuro.com | 2016 | Redmond, United States | $41.03M | – | Medical devices for treating neurological disorders like epilepsy are developed. | |
| engagetherapeutics.com | 2017 | Summit, United States | $30.6M | – | Inhaled drug-device combo as rescue treatment for uncontrolled epileptic seizures | |
| nightwatchepilepsy.com | 2013 | Leiden, Netherlands | – | – | Wearable armbands for detecting epileptic seizures during sleep are offered. | |
| cyberonics.com | 1987 | Houston, United States | – | 660 | Vagus nerve stimulation therapy is developed for epilepsy and depression. | |
| cerbomed.de | 2005 | Erlangen, Germany | $2.6M | – | Neuro-therapy solutions are developed for drug-resistant epilepsies and disorders. | |
| precisis.de | 2002 | Heidelberg, Germany | – | 14 | Devices and tools for neurological surgery are developed. | |
| oceansbio.com | 2021 | Changwon, South Korea | – | – | Electroceutical devices for epilepsy treatment are developed with AI integration. |
Detailed competitors of Neurolink
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Neurolink
10 companies that operate in the same segment as Neurolink (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | – | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Neurolink
Neurolink was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Neurolink is headquartered in San Antonio, United States. It is registered at San Antonio, Texas, United States.
Neurolink is a funded company, having raised a total of $3.88M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.62M, raised on Oct 2010.
Neurolink operates with a B2B model, focusing on providing healthcare solutions, developing medical devices, neurology, and epilepsy treatment. Develops drug-device combinations for epilepsy treatment. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations. It continues to evolve, meeting industry challenges with strategic approaches.
Neurolink's top competitors include NeuroPace, Engage Therapeutics and Cyberonics.